{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:47:45Z","timestamp":1768006065832,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10067-023-06846-8","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T09:02:43Z","timestamp":1709542963000},"page":"1615-1622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality"],"prefix":"10.1007","volume":"43","author":[{"given":"Sebasti\u00e1n","family":"Udry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 O.","family":"Latino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie Morales","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Belizna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Esteve-Valverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Per\u00e9s","family":"Wingeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego S. Fern\u00e1ndez","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9212-3619","authenticated-orcid":false,"given":"Jaume","family":"Alijotas-Reig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"de Larra\u00f1aga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"issue":"7","key":"6846_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41584-018-0032-6","volume":"14","author":"PL Meroni","year":"2018","unstructured":"Meroni PL, Borghi MO, Grossi C, Chighizola CB, Durigutto P, Tedesco F (2018) Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases? Nat Rev Rheumatol 14(7):433\u2013440. https:\/\/doi.org\/10.1038\/s41584-018-0032-6","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6846_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13023-021-01906-1","volume":"16","author":"M Radin","year":"2021","unstructured":"Radin M, Foddai SG, Barinotti A, Cecchi I, Rubini E, Sciascia S et al (2021) Reducing the diagnostic delay in antiphospholipid syndrome over time: a real world observation. Orphanet J Rare Dis 16(1):280. https:\/\/doi.org\/10.1186\/s13023-021-01906-1","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"6846_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13023-020-01374-z","volume":"15","author":"C Faviez","year":"2020","unstructured":"Faviez C, Chen X, Garcelon N, Neuraz A, Knebelmann B, Salomon R et al (2020) Diagnosis support systems for rare diseases: a scoping review. Orphanet J Rare Dis 15(1):94. https:\/\/doi.org\/10.1186\/s13023-020-01374-z","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"6846_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thrombosis Haemostasis\u202f: JTH 4(2):295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thrombosis Haemostasis : JTH"},{"key":"6846_CR5","doi-asserted-by":"publisher","unstructured":"Bulletins--Obstetrics ACoP. (2002) ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstetrics and gynecology. 99(1):159\u201367. https:\/\/doi.org\/10.1016\/s0029-7844(01)01747-1.","DOI":"10.1016\/s0029-7844(01)01747-1"},{"issue":"9","key":"6846_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0961203317692432","volume":"26","author":"JO Latino","year":"2017","unstructured":"Latino JO, Udry S, Aranda FM, Peres Wingeyer SDA, Fernandez Romero DS, de Larranaga GF (2017) Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile. Lupus 26(9):983\u2013988. https:\/\/doi.org\/10.1177\/0961203317692432","journal-title":"Lupus"},{"issue":"5","key":"6846_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s12026-018-9024-5","volume":"66","author":"JO Latino","year":"2018","unstructured":"Latino JO, Udry S, Wingeyer SP, Romero DF, Micone P, de Larranaga G (2018) What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients? Immunol Res 66(5):577\u2013583. https:\/\/doi.org\/10.1007\/s12026-018-9024-5","journal-title":"Immunol Res"},{"issue":"4","key":"6846_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.autrev.2018.12.006","volume":"18","author":"J Alijotas-Reig","year":"2019","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Saez-Comet L, Lefkou E, Mekinian A et al (2019) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases. Autoimmun Rev 18(4):406\u2013414. https:\/\/doi.org\/10.1016\/j.autrev.2018.12.006","journal-title":"Autoimmun Rev"},{"issue":"6","key":"6846_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.medcli.2017.11.017","volume":"151","author":"J Alijotas-Reig","year":"2018","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, LLurba E, Ruffatti A, Tincani A et al (2018) Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies. Medicina clinica. 151(6):215\u201322. https:\/\/doi.org\/10.1016\/j.medcli.2017.11.017","journal-title":"Medicina clinica."},{"issue":"6","key":"6846_CR10","first-page":"382","volume":"19","author":"LJ Jara","year":"2017","unstructured":"Jara LJ, Medina G, Cruz-Cruz P, Olivares-Rivera J, Duarte-Salazar C, Saavedra MA (2017) Non-criteria or seronegative obstetric antiphospholipid syndrome? The Israel Med Ass J: IMAJ 19(6):382\u2013386","journal-title":"The Israel Med Ass J: IMAJ"},{"key":"6846_CR11","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3389\/fimmu.2019.01948","volume":"10","author":"MG Lazzaroni","year":"2019","unstructured":"Lazzaroni MG, Fredi M, Andreoli L, Chighizola CB, Del Ross T, Gerosa M et al (2019) Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: a multicenter study on 62 pregnancies. Front Immunol 10:1948. https:\/\/doi.org\/10.3389\/fimmu.2019.01948","journal-title":"Front Immunol"},{"issue":"6","key":"6846_CR12","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/rheumatology\/kez419","volume":"59","author":"J Alijotas-Reig","year":"2020","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Saez-Comet L, Lefkou E, Mekinian A et al (2020) Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry. Rheumatology 59(6):1306\u20131314. https:\/\/doi.org\/10.1093\/rheumatology\/kez419","journal-title":"Rheumatology"},{"issue":"9","key":"6846_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nrrheum.2017.124","volume":"13","author":"S Sciascia","year":"2017","unstructured":"Sciascia S, Amigo MC, Roccatello D, Khamashta M (2017) Diagnosing antiphospholipid syndrome: \u2018extra-criteria\u2019 manifestations and technical advances. Nat Rev Rheumatol 13(9):548\u2013560. https:\/\/doi.org\/10.1038\/nrrheum.2017.124","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6846_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semarthrit.2017.12.006","volume":"48","author":"M Radin","year":"2018","unstructured":"Radin M, Ugolini-Lopes MR, Sciascia S, Andrade D (2018) Extra-criteria manifestations of antiphospholipid syndrome: risk assessment and management. Semin Arthritis Rheum 48(1):117\u2013120. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.12.006","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"6846_CR15","first-page":"234","volume":"31","author":"L Stojanovich","year":"2013","unstructured":"Stojanovich L, Kontic M, Djokovic A, Marisavljevic D, Ilijevski N, Stanisavljevic N et al (2013) Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study. Clin Exp Rheumatol 31(2):234\u2013242","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"6846_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/0961203309355300","volume":"19","author":"D Erkan","year":"2010","unstructured":"Erkan D, Barbhaiya M, George D, Sammaritano L, Lockshin M (2010) Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information? Lupus 19(5):613\u2013619. https:\/\/doi.org\/10.1177\/0961203309355300","journal-title":"Lupus"},{"issue":"3","key":"6846_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/09612033221078223","volume":"31","author":"S Udry","year":"2022","unstructured":"Udry S, Perez SM, Belizna C, Aranda F, Esteve-Valverde E, Wingeyer SP et al (2022) Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome. Lupus 31(3):354\u2013362. https:\/\/doi.org\/10.1177\/09612033221078223","journal-title":"Lupus"},{"key":"6846_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3389\/fimmu.2018.00864","volume":"9","author":"M Fredi","year":"2018","unstructured":"Fredi M, Andreoli L, Aggogeri E, Bettiga E, Lazzaroni MG, Le Guern V et al (2018) Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: results from a multicenter study of 283 pregnancies. Front Immunol 9:864. https:\/\/doi.org\/10.3389\/fimmu.2018.00864","journal-title":"Front Immunol"},{"issue":"10","key":"6846_CR19","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/ard-2023-224609","volume":"82","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F et al (2023) 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis 82(10):1258\u20131270. https:\/\/doi.org\/10.1136\/ard-2023-224609","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06846-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06846-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06846-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T05:11:30Z","timestamp":1713157890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06846-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6846"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06846-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}